These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7731703)

  • 21. DNA methylation differences associated with tumor tissues identified by genome scanning analysis.
    Liang G; Salem CE; Yu MC; Nguyen HD; Gonzales FA; Nguyen TT; Nichols PW; Jones PA
    Genomics; 1998 Nov; 53(3):260-8. PubMed ID: 9799591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in the tumor suppressor gene p53 in human liver cancer induced by alpha-particles.
    Andersson M; Jönsson M; Nielsen LL; Vyberg M; Visfeldt J; Storm HH; Wallin H
    Cancer Epidemiol Biomarkers Prev; 1995; 4(7):765-70. PubMed ID: 8672994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma.
    Zhang L; Lu W; Miao X; Xing D; Tan W; Lin D
    Carcinogenesis; 2003 Jun; 24(6):1039-44. PubMed ID: 12807758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypermethylation of the DNA repair gene MGMT: association with TP53 G:C to A:T transitions in a series of 469 nervous system tumors.
    Bello MJ; Alonso ME; Amiñoso C; Anselmo NP; Arjona D; Gonzalez-Gomez P; Lopez-Marin I; de Campos JM; Gutierrez M; Isla A; Kusak ME; Lassaletta L; Sarasa JL; Vaquero J; Casartelli C; Rey JA
    Mutat Res; 2004 Oct; 554(1-2):23-32. PubMed ID: 15450401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of p53 mutations for a mutational signature in human intrahepatic cholangiocarcinoma.
    Khan SA; Taylor-Robinson SD; Carmichael PL; Habib N; Lemoine NR; Thomas HC
    Int J Oncol; 2006 May; 28(5):1269-77. PubMed ID: 16596244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The distribution of UV photoproducts along the human p53 gene and its relation to mutations in skin cancer.
    Tornaletti S; Rozek D; Pfeifer GP
    Oncogene; 1993 Aug; 8(8):2051-7. PubMed ID: 8336934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens.
    Puisieux A; Lim S; Groopman J; Ozturk M
    Cancer Res; 1991 Nov; 51(22):6185-9. PubMed ID: 1933877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors.
    Stirzaker C; Millar DS; Paul CL; Warnecke PM; Harrison J; Vincent PC; Frommer M; Clark SJ
    Cancer Res; 1997 Jun; 57(11):2229-37. PubMed ID: 9187126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in methylation patterns in the methylation boundary region of IDS gene in Hunter syndrome patients: implications for CpG hot spot mutations.
    Tomatsu S; Sukegawa K; Trandafirescu GG; Gutierrez MA; Nishioka T; Yamaguchi S; Orii T; Froissart R; Maire I; Chabas A; Cooper A; Di Natale P; Gal A; Noguchi A; Sly WS
    Eur J Hum Genet; 2006 Jul; 14(7):838-45. PubMed ID: 16617305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Base excision repair of U:G mismatches at a mutational hotspot in the p53 gene is more efficient than base excision repair of T:G mismatches in extracts of human colon tumors.
    Schmutte C; Yang AS; Beart RW; Jones PA
    Cancer Res; 1995 Sep; 55(17):3742-6. PubMed ID: 7641186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of p53 gene mutations in colorectal carcinomas from an Asian population.
    Shi CY; Phang TW; Ngoi SS; Wee A; Li B; Lin Y; Lee HP; Ong CN
    Anticancer Res; 1994; 14(6B):2811-6. PubMed ID: 7872723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
    Kao RH; Huang LC; Hsu YH
    Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
    Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The loss of dinucleotides CpG from DNA. IV. Methylation and divergence of genes and pseudogenes of small nuclear RNA].
    Mazin AL; Vaniushin BF
    Mol Biol (Mosk); 1987; 21(4):1099-109. PubMed ID: 3657781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
    Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
    Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Li-Fraumeni and Li-Fraumeni-like syndrome mutations in p53 are associated with exonic methylation and splicing regulatory elements.
    Kouidou S; Malousi A; Maglaveras N
    Mol Carcinog; 2009 Oct; 48(10):895-902. PubMed ID: 19367569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylation patterns of the human beta-glucuronidase gene locus: boundaries of methylation and general implications for frequent point mutations at CpG dinucleotides.
    Tomatsu S; Orii KO; Islam MR; Shah GN; Grubb JH; Sukegawa K; Suzuki Y; Orii T; Kondo N; Sly WS
    Genomics; 2002 Mar; 79(3):363-75. PubMed ID: 11863366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sunlight induces pyrimidine dimers preferentially at 5-methylcytosine bases.
    Tommasi S; Denissenko MF; Pfeifer GP
    Cancer Res; 1997 Nov; 57(21):4727-30. PubMed ID: 9354431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
    Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R
    Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogenous point mutations in the BRCA1 breast cancer susceptibility gene occur in high frequency at the site of homonucleotide tracts, short repeats and methylatable CpG/CpNpG motifs.
    Rodenhiser D; Chakraborty P; Andrews J; Ainsworth P; Mancini D; Lopes E; Singh S
    Oncogene; 1996 Jun; 12(12):2623-9. PubMed ID: 8700521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.